Catalyst Calendar

Tue, Sep 8, 2026

1 updates

8:03 AM

Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Company Presentation to Highlight Lead Clinical Oncology Program and Preclinical Diabetes Program AUSTIN, Texas — (Sept. 8, 2026) — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX ), today announced that members of its executive leadership team will present at and participate in the H.C....

genprex.com

Tue, Aug 18, 2026

1 updates

GNPX

7:03 AM

Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy

Collaboration Allows Genprex to Accelerate Manufacturing Processes for IND-Enabling Preclinical Studies and Future Clinical Trials AUSTIN, Texas — (Aug.18, 2026) — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ:...

genprex.com

Mon, Aug 3, 2026

1 updates

GNPX

7:03 AM

Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies

Collaboration Advances Biomarker-Driven Patient Selection and Precision Medicine in Oncology Validation Studies Aim to Optimize Clinical Trial Patient Selection Criteria AUSTIN, Texas — (Aug. 3, 2026) — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ:...

genprex.com